Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study

恩帕吉菲 医学 2型糖尿病 糖化血红素 血糖性 联合疗法 临床终点 内科学 不利影响 糖尿病 药理学 胰岛素 临床试验 内分泌学
作者
Kohei Kaku,Y. Nakayama,Junko Yabuuchi,Yusuke Naito,Keizo Kanasaki
出处
期刊:Expert Opinion on Drug Safety [Informa]
卷期号:: 1-14
标识
DOI:10.1080/14740338.2023.2213477
摘要

Background Sodium-glucose co-transporter-2 (SGLT2) inhibitors such as empagliflozin are increasingly prescribed as initial glucose-lowering drugs for type 2 diabetes (T2D), based on their cardiorenal benefits. However, information regarding the safety and the effectiveness of monotherapy with SGLT2 inhibitors in routine clinical practice is limited.Research design and methods We analyzed data from a prospective, 3-year, post-marketing surveillance study of empagliflozin in Japan. We evaluated adverse drug reactions (ADRs) (the primary endpoint) and glycemic effectiveness with or without other glucose-lowering drugs.Results 7931 T2D patients were treated with empagliflozin. At baseline, mean age was 58.7 years, 63.0% were male, and 1835 (23.14%) were not receiving other glucose-lowering drugs. ADRs occurred in 141 (7.68%) and 875 (14.62%) patients initiating empagliflozin as monotherapy or combination therapy, respectively. The most frequent ADRs of special interest with empagliflozin as monotherapy or combination therapy were urinary tract infections (0.82% and 1.14% of patients, respectively) and excessive/frequent urination (0.65%, 1.50%). At last observation, glycated hemoglobin level was reduced by a mean of 0.78% with empagliflozin monotherapy (from baseline mean of 7.55%) and 0.74% with combination therapy (baseline 8.16%).Conclusions Empagliflozin is well tolerated and effective in clinical practice in Japan when initiated as monotherapy or combination therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
每天多动一点点完成签到,获得积分10
1秒前
1秒前
所所应助单薄惜梦采纳,获得10
2秒前
小布发布了新的文献求助10
2秒前
yh完成签到,获得积分10
3秒前
5秒前
小王小王发布了新的文献求助10
5秒前
铁路桥发布了新的文献求助10
6秒前
陈尹蓝发布了新的文献求助10
6秒前
香蕉觅云应助一叶扁舟。采纳,获得10
9秒前
安详的书本完成签到 ,获得积分10
9秒前
冷酷思远发布了新的文献求助10
10秒前
CSPC001完成签到,获得积分10
11秒前
12秒前
所所应助rjj001022采纳,获得10
12秒前
劉劉完成签到 ,获得积分10
13秒前
未来完成签到,获得积分10
13秒前
14秒前
利利完成签到,获得积分10
14秒前
聚乙烯醇完成签到,获得积分10
16秒前
17秒前
大道无形我有型完成签到,获得积分10
17秒前
19秒前
老水发布了新的文献求助10
19秒前
kyycr完成签到,获得积分10
20秒前
NexusExplorer应助耶zyf采纳,获得10
20秒前
20秒前
啊实打实的完成签到,获得积分20
20秒前
隐形曼青应助月亮煮粥采纳,获得10
20秒前
21秒前
21秒前
火速阿百川完成签到,获得积分10
22秒前
rjj001022完成签到,获得积分10
22秒前
别当真发布了新的文献求助10
23秒前
优雅的金连完成签到,获得积分10
24秒前
YHY完成签到,获得积分10
24秒前
26秒前
26秒前
老水完成签到,获得积分10
27秒前
Yeah完成签到,获得积分10
28秒前
高分求助中
中国国际图书贸易总公司40周年纪念文集 大事记1949-1987 2000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
草地生态学 880
Threaded Harmony: A Sustainable Approach to Fashion 799
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3058079
求助须知:如何正确求助?哪些是违规求助? 2714263
关于积分的说明 7439873
捐赠科研通 2359489
什么是DOI,文献DOI怎么找? 1250095
科研通“疑难数据库(出版商)”最低求助积分说明 607383
版权声明 596392